Genetic Testing and Insurance: Where Privacy Protections Fall Short

Someone spits into a tube for an ancestry report. Months later, the company adds health insights, including a raised risk for a hereditary condition. A reasonable question follows: could this ever affect my insurance?

The short answer on genetic testing and insurance is that federal law protects some situations and leaves others open. The National Human Genome Research Institute states that the Genetic Information Nondiscrimination Act (GINA) covers health insurance and employment but does not apply to life, disability, or long-term care insurance. State law fills part of the gap, unevenly.

The Insurance Question in One Table

Insurance typeGINA protectionMain issue to check
Health insuranceCoveredFederal rules, plus state additions
EmploymentCovered (employers with 15+ workers)Requests for family history, hiring decisions
Life insuranceNot coveredState law and insurer underwriting practices
Disability insuranceNot coveredState-specific rules
Long-term care insuranceNot coveredState-specific rules

State laws differ widely. Roughly half of states regulate how genetic information may be used in underwriting, and the strength of those rules varies. Florida’s 2020 law, HB 1189, was the first to bar life, disability, and long-term care insurers from using genetic test results. Never assume that one national rule applies everywhere.

What Counts as Genetic Information?

GINA defines genetic information broadly. It includes:

  • Results of a person’s own genetic tests
  • Genetic tests of family members
  • Family medical history, which the law treats as a proxy for genetic risk
  • Participation in genetic research or counseling
  • Carrier status for recessive conditions

Genetic information differs from a diagnosis. A positive BRCA1 result signals higher cancer risk but does not mean cancer exists. A diagnosed disease sits in a medical record and is treated differently by underwriters than a risk-only result. That difference is exactly where gaps appear.

What GINA Actually Protects

Title I prohibits health insurers from using genetic information to set eligibility or premiums, and from requiring genetic tests. Title II bars employers from using genetic information in hiring, firing, pay, or promotion, and limits when they can request it. The Affordable Care Act separately prevents health plans from denying coverage for pre-existing conditions.

GINA does not cover everyone and everything. It excludes life, disability, and long-term care insurance. It also has limits for members of the military and some federal health programs. It is an antidiscrimination law, not a general genetic privacy law. It does not govern who may sell or share consumer DNA data.

Where the Legal Gaps Matter Most

Before buying life insurance

Life insurers ask about medical history, family history, and sometimes test results. In many states, a person who has already learned of a high-risk result may face higher premiums or a denial. Some people choose to buy coverage before testing, but such timing decisions should be weighed carefully with a licensed professional.

Before applying for long-term care insurance

Underwriting often occurs at age 50 to 65, when genetic risks for conditions like dementia may be known. Long-term care carriers can legally consider genetic information in states without protective statutes. A person with a known APOE result or a hereditary disease should check state rules first.

After taking a direct-to-consumer DNA test

Many consumer results are not part of a medical record. Even so, applications may ask whether the applicant has had genetic testing. Insurer disclosure rules and state law determine what must be answered. Reading the application questions and the testing company’s terms is a necessary first step.

Because no single national rule applies, readers should check their state insurance department and insurer disclosures rather than relying on general assumptions.

How Insurers Actually Underwrite

Life and long-term care underwriting relies on several data sources. Applicants answer health questions, insurers may request medical records, and they often check prescription histories and prior application databases. A genetic test result becomes relevant if it sits in a medical record or if the application asks about it directly.

Accuracy of answers matters. Most life policies include a contestability period, commonly two years, during which an insurer can investigate and potentially void a policy for material misstatements. Applicants should answer truthfully and ask the agent what the form requires.

How State Rules Differ

ApproachWhat it meansExample
Broad banInsurers cannot use genetic test results for life, disability, or long-term careFlorida
Partial rulesLimits on requiring tests or on using results without a diagnosisSeveral states
Consent and disclosure rulesInsurers must get consent or explain useVarious states
No specific lawGeneral insurance fairness rules onlyMany states

Because the rules keep changing, state insurance department websites and the National Human Genome Research Institute’s table of state statutes are the best places to check current rules. A licensed agent or attorney familiar with the applicant’s state can add clarity.

The Ethical Problem Is Bigger Than Insurance

Insurance is one of several concerns. Informed consent matters when results may reveal unexpected disease risk. Autonomy matters when people prefer not to know. Data ownership, commercialization, and secondary use of samples raise further questions. Future uses of today’s data are impossible to predict.

The 2025 bankruptcy of 23andMe made this concrete. The company held data from roughly 15 million customers, and the Federal Trade Commission warned that any buyer must honor existing privacy commitments. A nonprofit led by co-founder Anne Wojcicki acquired the assets for about $305 million. The episode showed that privacy depends partly on corporate stability.

Details About Health Insurance That Surprise People

Health coverage is the strongest area of protection, but some details still confuse readers. GINA stops insurers from using predictive genetic information. It does not stop them from considering a disease after it has been diagnosed. Once a condition appears, it is a medical fact, though the Affordable Care Act separately prevents most plans from denying coverage or charging more because of it.

Not every product follows the same rules. Short-term and other limited-benefit plans can be underwritten differently under federal and state law, so buyers should read the terms carefully. Members of the military and veterans have separate frameworks through TRICARE and the VA.

Why Fear of Discrimination Matters

Research has found that worry about insurance consequences can discourage people from genetic testing, even when testing could guide prevention. Someone with a strong family history of cancer might avoid a BRCA test because of life insurance concerns, delaying screening that could save their life. That is a public health cost of weak protections, and it is one reason lawmakers and genetic counselors continue to push for broader federal coverage.

Who Else May Access Genetic Data?

PartyTypical accessKey point
Testing companyRaw data, resultsGoverned by privacy policy and consent
Healthcare providersClinical test resultsCovered by HIPAA
ResearchersDe-identified or consented dataOpt-in is common but varies
Data partnersShared data under agreementCheck third-party sharing terms
Law enforcementVia legal process or public databasesPolicies differ by company
RelativesIndirectly, through shared DNACannot be opted out of by others

Consumer testing companies are generally not covered by HIPAA. Their obligations come from their own privacy policies, state genetic privacy laws, and FTC oversight over deceptive practices.

One Person’s DNA Reveals Information About Others

Genetic information is unusually relational. A parent shares about half of their DNA with each child, and siblings share about half on average. A result for one person can imply risk for biological relatives who never agreed to be tested.

This raises hard questions. Should a person tell siblings about a hereditary cancer variant? Should a doctor encourage it? Many genetic counselors recommend sharing medically actionable results with relatives who could benefit from screening. The decision remains personal, and relatives may choose not to know.

What to Check Before Ordering a DNA Test

  • Privacy policy: Look for clear statements about how data is used.
  • Data retention: Learn how long samples and raw data are kept.
  • Research consent: Check whether participation is opt-in or opt-out.
  • Deletion policy: Confirm that data and physical samples can be destroyed.
  • Third-party sharing: Identify partners that may receive data.
  • Law enforcement policy: Read how requests are handled.
  • Insurance implications: Review state law and application questions.
  • Data portability: See whether results can be downloaded or transferred.
  • Reinterpretation: Ask whether results will be updated as science changes.

If a Test Has Already Been Taken

Some readers have results in hand and questions about what to do next. A few steps are sensible. Keep a copy of the results and the testing company’s privacy terms. Look up the state’s rules for life, disability, and long-term care insurance before applying. Answer application questions truthfully, since misstatements can create problems later.

A genetic counselor can explain what a result does and does not mean, which matters because many consumer reports describe risk, not certainty. Anyone considering long-term care coverage may also want to ask an independent agent about timing, because underwriting rules and premiums often change with age.

Why the Gap Exists: The Insurer’s Argument

Understanding both sides explains why the law looks the way it does. Insurers argue that life and long-term care policies are priced on the applicant’s expected health. If applicants know a high-risk result and insurers cannot ask, high-risk people could buy large policies at average prices, a problem called adverse selection. Premiums for everyone would then rise.

Consumer advocates and genetic counselors respond that the argument is weakest where the information is a probability, not a diagnosis. That fear of discrimination keeps people from testing even when results could save their lives. Both claims have some support, which is why different countries strike different balances.

How Other Countries Handle It

CountryApproachNotes
United StatesGINA covers health insurance and employmentNo federal limit for life, disability, long-term care
CanadaGenetic Non-Discrimination Act, 2017Bars requiring genetic tests or disclosure; Supreme Court upheld it in 2020
United KingdomVoluntary code with the insurance industryInsurers do not require predictive tests, with a narrow exception for Huntington’s disease on very large life policies
AustraliaGovernment announced plans in 2024 to ban use in life insuranceCheck whether legislation has taken effect

The comparison shows that strong protections are possible without collapsing insurance markets, and that US protections are narrower than those in several peer countries.

Genetic Data and Law Enforcement

Genetic data have uses beyond insurance. In 2018, investigators identified a suspect in the Golden State Killer case by matching crime-scene DNA with relatives in a public genealogy database. The case showed that a person can be identified through relatives who tested, even if they never did.

Companies now set their own rules. Some refuse law enforcement requests without a warrant, and some allow users to opt out of relative matching. Users should read the current policy, because policies change.

What Each Checklist Item Means

The ordering checklist above is only useful if each item is understood.

Privacy policy. Look for plain statements on who can see data, whether data is sold, and how a policy change would be announced. Vague language such as “partners” without definition is a warning sign.

Data retention. Some companies keep raw data and saved saliva for years. Longer retention increases exposure in a breach, sale, or bankruptcy.

Research consent. Many companies ask users to join internal or partnered research. Opting in can advance science, but it can also move data into new hands. Consent should be separate from the purchase.

Deletion policy. Confirm that you can delete your account, your data, and any stored sample, and learn how long deletion takes. Check whether data already shared with researchers can be withdrawn.

Third-party sharing. Identify who receives data, for what purpose, and in what form. De-identified data can sometimes be re-identified when combined with other datasets.

Law enforcement policy. Find out whether the company requires a warrant, publishes transparency reports, and lets users opt out of matching.

Insurance implications. Review state law and the questions asked on life, disability, and long-term care applications before testing, not after.

Data portability. Being able to download raw data lets a person move to another service or share it with a clinician.

Reinterpretation. Science changes. A good service updates results or explains how reinterpretation works, because a variant labeled uncertain today may be reclassified.

Weighing the Value Against the Risk

Genetic information can guide screening, prevention, and treatment decisions. It also exposes highly personal biology that cannot be changed or fully retracted. The balance depends on the type of test, the quality of the privacy terms, and the state a person lives in.

A practical final step is simple. Before ordering or sharing results, read the privacy terms, check state insurance protections, and consider talking to a genetic counselor. Informed decisions beat assumptions in this area.

The central lesson is that genetic privacy is not one right but a patchwork of protections that change with the type of insurance, the state, and the company holding the data. Understanding that patchwork before testing is far easier than repairing the consequences afterward.

Policy may also shift. Several states have passed or considered genetic privacy bills, federal proposals periodically target the life insurance gap, and some countries are tightening rules. Readers who test should check current law at the time, and those who work in healthcare or insurance should expect continuing debate about where the line belongs.

Disclaimer: Genetic testing and insurance laws are complex and vary by jurisdiction. This article is general information and is not a substitute for medical, genetic counseling, legal, or insurance advice.

FAQ

Q: Can genetic testing affect health insurance?

A: Under GINA, health insurers cannot use genetic information to deny coverage or set premiums. The ACA also bars pre-existing condition exclusions. State laws may add further protections.

Q: Does GINA protect life insurance?

A: No. GINA does not apply to life insurance. Protections depend on state law, and most states offer limited coverage.

Q: Can life insurers ask about genetic testing?

A: In many states, yes. Underwriting questions about medical history and test results can be legal, and answers may affect premiums or eligibility. Florida restricts this practice.

Q: Is DNA information private?

A: Only to the extent that laws and company policies make it so. Consumer testing companies are usually outside HIPAA, so their privacy policies and state laws matter.

Q: Can employers use genetic information?

A: GINA generally prohibits employers with 15 or more employees from using genetic information in employment decisions and from requesting it, with narrow exceptions.

Q: Does GINA apply to long-term care insurance?

A: No. Long-term care insurers are not covered by GINA, so state law is the main source of protection.

Q: Can genetic test results affect family members?

A: Yes. A result can reveal shared inherited risk for biological relatives, even if they were never tested. This creates ethical and privacy questions.

Q: What should be checked before taking a direct-to-consumer DNA test?

A: Review the privacy policy, data retention, third-party sharing, law enforcement requests, deletion options, and any insurance consequences in the state of residence.

Leave a Reply

Your email address will not be published. Required fields are marked *